- Home
- XGN vs LEGT Comparison
XGN vs LEGT Comparison
Compare XGN & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- LEGT
- Stock Information
- Founded
- XGN 2002
- LEGT 2023
- Country
- XGN United States
- LEGT United States
- Employees
- XGN N/A
- LEGT N/A
- Industry
- XGN Medical Specialities
- LEGT
- Sector
- XGN Health Care
- LEGT
- Exchange
- XGN Nasdaq
- LEGT Nasdaq
- Market Cap
- XGN 253.9M
- LEGT 278.6M
- IPO Year
- XGN 2019
- LEGT 2024
- Fundamental
- Price
- XGN $7.47
- LEGT $10.81
- Analyst Decision
- XGN Strong Buy
- LEGT
- Analyst Count
- XGN 6
- LEGT 0
- Target Price
- XGN $13.67
- LEGT N/A
- AVG Volume (30 Days)
- XGN 460.9K
- LEGT 172.4K
- Earning Date
- XGN 11-04-2025
- LEGT 01-01-0001
- Dividend Yield
- XGN N/A
- LEGT N/A
- EPS Growth
- XGN N/A
- LEGT N/A
- EPS
- XGN N/A
- LEGT 0.33
- Revenue
- XGN $63,599,000.00
- LEGT N/A
- Revenue This Year
- XGN $22.50
- LEGT N/A
- Revenue Next Year
- XGN $14.75
- LEGT N/A
- P/E Ratio
- XGN N/A
- LEGT $32.88
- Revenue Growth
- XGN 14.08
- LEGT N/A
- 52 Week Low
- XGN $2.67
- LEGT $10.27
- 52 Week High
- XGN $12.23
- LEGT $11.25
- Technical
- Relative Strength Index (RSI)
- XGN 18.36
- LEGT 44.49
- Support Level
- XGN $9.19
- LEGT $10.80
- Resistance Level
- XGN $8.35
- LEGT $10.90
- Average True Range (ATR)
- XGN 0.59
- LEGT 0.08
- MACD
- XGN -0.27
- LEGT -0.02
- Stochastic Oscillator
- XGN 0.59
- LEGT 4.35
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.